Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167401 · ClinicalTrials.gov registry record · Phase 2
Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer
A Phase 2 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00167401: Completed Phase 2 study, sponsored by University of Rochester.
NCT00167401 is a Phase 2 study that has completed, run by University of Rochester. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00167401, a Phase 2 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The University of Rochester Cancer Center (URCC) is conducting a research study at Highland Hospital and Strong Memorial of lung cancer patients whose tumors cannot be surgically removed. The usual treatment for this stage of cancer is chemotherapy (treatment with drugs) combined with radiation (chemo-radiation). Because of the risk of spread to other organs, patients with your stage of disease are also often treated with additional chemotherapy, either before or after the chemo-radiation treatment. The best timing and number of treatments for this additional chemotherapy has not been clearly established. The purpose of this study is to help determine if a single treatment with two chemotherapy drugs, followed by radiation and low-dose chemotherapy is an effective way to treat patients with lung cancer. The side effects of this treatment and your quality of life while on the study will also be studied. Eighteen will participate in this study locally.
Interventions
- DRUG cisplatin
- DRUG docetaxel
- PROCEDURE radiation treatment
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-02 |
| Phase | Phase 2 |
What the finished NCT00167401 record still lists
NCT00167401 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which cisplatin is the first listed.
NCT00167401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00167401 about?
NCT00167401 is a clinical study titled "Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer". The University of Rochester Cancer Center (URCC) is conducting a research study at Highland Hospital and Strong Memorial of lung cancer patients whose tumors cannot be surgically removed. The usual treatment for this stage of cancer is chemotherapy (treatment with drugs) combined with radiation (che...
What is the current status of trial NCT00167401?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-02.
What interventions are being tested in trial NCT00167401?
The interventions under investigation include: cisplatin (DRUG), docetaxel (DRUG), radiation treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00167401?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia